Pembrolizumab in Preventing Lung Cancer in Patients With Stage I-II Non-Small Cell Lung Cancer or High-Risk Pulmonary Nodules, the IMPRINT-Lung Study
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Vastra Gotaland Region
Montefiore Medical Center
Henan Cancer Hospital
IO Biotech
AstraZeneca
M.D. Anderson Cancer Center
Brown University
Novartis
University of Chicago
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
Pfizer
Daiichi Sankyo
Duke University
Seagen Inc.
University of Kentucky
NYU Langone Health
Endeavor Biomedicines, Inc.
Jiangsu HengRui Medicine Co., Ltd.
Tianjin Medical University Cancer Institute and Hospital
H. Lee Moffitt Cancer Center and Research Institute
MedSIR
BeOne Medicines
ETOP IBCSG Partners Foundation
University Hospital, Lille
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
Eli Lilly and Company
Bristol-Myers Squibb
Boehringer Ingelheim
Big Ten Cancer Research Consortium
Genentech, Inc.
Hunan Cancer Hospital
Novartis
AstraZeneca
Samsung Medical Center
Anhui Provincial Hospital
Revolution Medicines, Inc.
BeOne Medicines
Centre Henri Becquerel
Seoul National University Hospital
University Health Network, Toronto
Fundación GECP
H. Lee Moffitt Cancer Center and Research Institute
Memorial Sloan Kettering Cancer Center
Massachusetts General Hospital
I-Mab Biopharma US Limited
Hoffmann-La Roche
Fundación GECP